Zane Cohen Centre - Professional Publications 2004

You are here: Home

GI Cancers

Familial Gastrointestinal Cancer Registry

Resources

Professional Publications

Professional Publications 2004

Cleary S, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004;198(5): pp 722-731.
Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S, Gilchrist D, Hughes R, Jackson CE, Monaghan KG, Oliveira MJ, Seruca R, Gallinger S, Caldas C, Huntsman D. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41(7): pp 508-517.
Swallow CJ, Partridge EA, Macmillan JC, Tajirian T, Di Guglielmo GM, Hay K, Szweras M, Jahnen-Dechent W, Wrana JL, Redston M, Gallinger S, Dennis JW. a 2HS-glycoprotein, an antagonist of transforming growth factor b in vivo, inhibits intestinal tumor progression. Cancer Res 2004; 64(18): pp 6402-6409.
Haddad R, Ogilvie RT, Croitoru M, Muniz V, Gryfe R, Pollet A, Shanmugathasan P, Fitzgerald T, Law CHL, Hanna SS, Jothy S, Redston M, Gallinger S, Smith AJ. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases. Annals of Surgical Oncology 2004; 11(11): pp 977-982.
Croitoru ME, Cleary S, Di Nicola N, Manno M, Selander T, Aronson M, Redston M, Cotterchio M, Knight J, Gryfe R, Gallinger S. The association between biallelic and monoallelic germline MYH mutations and colorectal cancer risk. J Natl Cancer Inst 2004; 96(21): pp 1631-1634.
Newman B, Silverberg MS , Gu X, Zhang Q, Lazaro A, Steinhart AH, Greenberg GR, Griffiths AM, McLeod RS, Cohen Z, Fernandez-Vina M, Amos CI, Siminovitch K. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. American Journal of Gastroenterology 2004; 99(2): 306-315.
van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM and the Genome Scan Meta-Analysis Group of the IBD International Genetics Consortium (Silverberg MS , contributing author). Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Human Molecular Genetics 2004;13 (7): 763-770.
Karban AS, Okzaki T, Panhuysen CIM, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS , Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar JP, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Human Molecular Genetics 2004;13(1):35-45.
Poritz L, Gagliano AG, McLeod RS, MacRae H, Cohen Z: Surgical management of cutaneous abdominal fistulae in crohn's disease - a 17 year experience. International Journal of Colorectal Disease 2004 ;19(5):481-5.
Johnson P, Richard C, Ravid A, Spencer L, Cohen Z, McLeod R: Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Disease Colon Rectum 2004 Jun 47:1119-1126.
Newman A, Silverberg M, Gu Z, Zhang Q, Lazaro A, Steinhart H, Greenberg G, McLeod R, Cohen Z, Fernandez-Vina M, Amos C, Siminovitch K: Card 15 HLADRB 1 alleles influences susceptibility and disease localization in Crohn's disease. American Journal of Gastroenterology 2004 Jun : 99: 306-315.
Esplen MJ, Hunter J, Leszcz M, Warner E, Narod S, Metcalfe K.,Glendon G, Butler K, Liede A, Young MA, Kieffer S, DiProspero L, Irwin E. A Multi-Centre phase II study of supportive-expressive group therapy for women with BRCA1 and BRCA2 Mutations. Cancer 2004; 101(10): 2327-2340.
Bottorff J, McCullum M, Balneaves LG, Esplen MJ, Caroll J, Kelly M, Kieffer S. Proceedings of the "Nursing in the Genomic Era: A Canadian Planning Forum". Canadian Nurse 2004;100(8):24-8.
Madlensky L, Esplen MJ, Goel V. Reasons given by relatives of colorectal cancer patients for not undergoing screening. Preventive Medicine 2004; 39(4):643-648.
Segal J,Esplen MJ, Toner B, Baedorf S, Narod S, Butler K. An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers. American Journal of Medical Genetics 2004; 125A(3):267-272.
Metcalfe KA, Esplen MJ, Goel V, Narod SA. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho-Oncology 2004;13(1): 14-25.
Esplen MJ, Berk T, Butler K, Gallinger S, Cohen Z, Trinkhuas B. Quality of life in adults diagnosed with familial adenomatous polyposis and desmoid tumor. Dis Colon Rectum 2004;47:pp.687-696.
Haddad R, Vincent JB, Gryfe R, Kim H, Wen J, Redston M, Scherer SW, Gallinger S. Chromosome 7q31 allelic imbalance and somatic mutations of RAY1/ST7 gene in colorectal cancer. Cancer Letters 2004:203: pp 87-90.
Gallinger S, (Co-First Author), Aronson M, (Co-First Author), Shayan K, Ratcliffe EM, Gerstle JT, Parkin PC, Rothenmund H, Croitoru M, Baumann E, Durie PR, Weksberg R, Pollett A, Riddell RH, Ngan BY, Cutz E, Lagarde AE, Chan HSL. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004: 126: pp 576-585.